We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Drugmakers to Inherit Safety Labeling Update Powers Under FDA Rule
Generic Drugmakers to Inherit Safety Labeling Update Powers Under FDA Rule
The FDA is proposing to give generic drugmakers the power to revise product labeling in response to safety issues prior to agency approval — a power that brand drugmakers already have.